Mean platelet volume may predict early clinical outcome after coronary artery bypass grafting

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Unal, Ertekin Utku ^a   Ozen, Anil ^a   Kocabeyoglu, Sabit ^a   Durukan, Ahmet Baris ^b   Tak, Sercan ^a   Songur, Murat ^a   Kervan, Umit ^a   Birincioglu, Cemal Levent ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Medicana International Hospital   (Turkey)

Author keywords

Coronary artery bypass; Hematocrit; Platelet function tests; Postoperative complications; Treatment outcome

Indexed keywords

EID: 84876081266     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-91     Document Type: Article

References (31)

1. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999, 15:816-822. 10.1016/S1010-7940(99)00106-2, 10431864.
2. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007, 357:2482-2494. 10.1056/NEJMra071014, 18077812.
3. Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, Endler G. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011, 31:1215-1218. 10.1161/ATVBAHA.110.221788, 21330610.
4. Wang RT, Li Y, Zhu XY, Zhang YN. Increased mean platelet volume is associated with arterial stiffness. Platelets 2011, 22:447-451. 10.3109/09537104.2011.565431, 21473674.
5. Varol E, Aksoy F, Ozaydin M, Erdogan D, Dogan A. Relationship between mean platelet volume and mitral annular calcification. Blood Coagul Fibrinolysis 2013, 24:189-193.
6. Guven A, Caliskan M, Ciftci O, Barutcu I. Increased platelet activation and inflammatory response in patients with masked hypertension. Blood Coagul Fibrinolysis 2013, 24:170-174.
7. Tavil Y, Sen N, Yazici HU, Hizal F, Açikgöz SK, Turfan M, Cengel A. Relationship between elevated platelet volume and saphenous vein graft disease. Clin Invest Med 2010, 33:E161-E167.
8. Erdem K, Ayhan S, Ozturk S, Bugra O, Bozoglan O, Dursin H, Yazici M, Daglar B. Usefulness of the mean platelet volume for predicting new-onset atrial fibrillation after isolated coronary bypass grafting. Platelets 2013, . Epub ahead of print.
9. Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002, 359:1747-1748. 10.1016/S0140-6736(02)08614-2, 12049866.
10. Fang WC, Helm RE, Krieger KH, Rosengart TK, DuBois WJ, Sason C, Lesser ML, Isom OW, Gold JP. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997, 96(Suppl 9):194-199.
11. Ferraris VA, Ferraris SP. Risk factors for postoperative morbidity. J Thorac Cardiovasc Surg 1996, 111:731-738. 10.1016/S0022-5223(96)70333-1, 8614133.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, . Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351. 10.1161/CIRCULATIONAHA.106.685313, 17470709, Academic Research Consortium.
13. Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA 1990, 264:2768-2774. 10.1001/jama.1990.03450210068035, 2232064.
14. O'Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, Nowicki ER, Levy DG, Tryzelaar JF, Hernandez F. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1992, 85:2110-2118. 10.1161/01.CIR.85.6.2110, 1591830.
15. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP, . Society of Thoracic Surgeons Quality Measurement Task Force The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009, 88(Suppl 1):2-22. Society of Thoracic Surgeons Quality Measurement Task Force.
16. Bell ML, Grunwald GK, Baltz JH, McDonald GO, Bell MR, Grover FL, Shroyer AL. Does preoperative hemoglobin independently predict short-term outcomes after coronary artery bypass graft surgery?. Ann Thorac Surg 2008, 86:1415-1423. 10.1016/j.athoracsur.2008.07.088, 19049724.
17. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT, . Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007, 116:471-479. 10.1161/CIRCULATIONAHA.106.653501, 17620512, Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation.
18. Bagger JP, Zindrou D, Taylor KM. Leukocyte count: a risk factor for coronary artery bypass graft mortality. Am J Med 2003, 115:660-663. 10.1016/S0002-9343(03)00438-8, 14656619.
19. Gibson PH, Croal BL, Cuthbertson BH, Small GR, Ifezulike AI, Gibson G, Jeffrey RR, Buchan KG, El-Shafei H, Hillis GS. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007, 154:995-1002. 10.1016/j.ahj.2007.06.043, 17967611.
20. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991, 338:1409-1411. 10.1016/0140-6736(91)92719-I, 1683417.
21. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010, 8:148-156. 10.1111/j.1538-7836.2009.03584.x, 19691485.
22. Dogan A, Aksoy F, Icli A, Arslan A, Varol E, Uysal BA, Ozaydin M, Erdogan D. Mean platelet volume is associated with culprit lesion severity and cardiac events in acute coronary syndromes without ST elevation. Blood Coagul Fibrinolysis 2012, 23:324-330. 10.1097/MBC.0b013e328352cb21, 22473051.
23. Zakkar M, Taylor K, Hornick PI. Immune system and inflammatory responses to cardiopulmonary bypass. Cardiopulmonary Bypass: Principles And Practice. 3rd Edition 2008, 321-337. Philadelphia: Lippincott Williams & Wilkins, Gravlee GP, Davis RF, Stammers AH, Ungerleider RM.
24. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivoby P-selectin on adherent platelets. Nature 1992, 359:848-851. 10.1038/359848a0, 1279433.
25. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591-594. 10.1038/35393, 9468137.
26. Mahla E, Suarez TA, Bliden KP, Rehak P, Metzler H, Sequeira AJ, Cho P, Sell J, Fan J, Antonino MJ, Tantry US, Gurbel PA. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012, 5:261-269. 10.1161/CIRCINTERVENTIONS.111.967208, 22396581.
27. Gurbel PA, Mahla E, Tantry US. Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks. Thromb Haemost 2011, 106:248-252. 10.1160/TH11-02-0063, 21505715.
28. Steele P, Battock D, Pappas G, Genton E. Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts. Circulation 1976, 53:685-687. 10.1161/01.CIR.53.4.685, 1082802.
29. Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, Wilson AC. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002, 144:636-641.
30. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W, . CAPRIE Investigators Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004, 35:1147-1152. 10.1161/01.STR.0000124122.71702.64, 15017013, CAPRIE Investigators.
31. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB, . Intermountain Heart Collaborative Study Group Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 2005, 45:1638-1643. 10.1016/j.jacc.2005.02.054, 15893180, Intermountain Heart Collaborative Study Group.